Minerva Surgical, Inc. provided revenue guidance for the full year 2022. The company expects full year 2022 revenue in the range of $60 million to $63 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.012 USD | +9.09% |
|
+9.09% | -98.97% |
Jan. 03 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index | CI |
2023 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-98.97% | 107K | |
+13.72% | 130B | |
-17.54% | 7.37B | |
+47.67% | 5.87B | |
-33.48% | 4.1B | |
+8.31% | 3.44B | |
-19.83% | 2.47B | |
-16.33% | 1.94B | |
-24.61% | 1.72B | |
-36.56% | 1.51B |
- Stock Market
- Equities
- UTRS Stock
- News Minerva Surgical, Inc.
- Minerva Surgical, Inc. Provides Revenue Guidance for the Full Year 2022